Inventiva S.A. (LON:0RNK)
2.680
-0.100 (-3.60%)
Mar 13, 2025, 4:28 PM BST
Inventiva Employees
As of December 31, 2023, Inventiva had 123 total employees, including 120 full-time and 3 part-time employees. The number of employees increased by 10 or 8.85% compared to the previous year.
Employees
123
Change (1Y)
10
Growth (1Y)
8.85%
Revenue / Employee
132.86K GBP
Profits / Employee
-718.14K GBP
Market Cap
215.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 25,408 |
Smith & Nephew | 17,000 |
ConvaTec Group | 10,000 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,988 |
Genus | 3,500 |
Inventiva News
- 15 days ago - Inventiva announces the publication in Biomedicine & Pharmacotherapy of the results from a preclinical study showing improvement of portal hypertension with lanifibranor treatment - GlobeNewsWire
- 21 days ago - Inventiva and Hepalys Pharma, Inc. announce the initiation of the clinical development program of lanifibranor in Japan with the dosing of the first participant in Phase 1 trial - GlobeNewsWire
- 4 weeks ago - Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update - GlobeNewsWire
- 6 weeks ago - Inventiva announces the publication of the results from the investigator-initiated proof-of-concept clinical trial evaluating lanifibranor in patients with T2D and MASLD in the Journal of Hepatology - GlobeNewsWire
- 6 weeks ago - Half-Year Review of Inventiva's Liquidity Contract with Kepler Cheuvreux - GlobeNewsWire
- 7 weeks ago - Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025 - GlobeNewsWire
- 3 months ago - Inventiva to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Inventiva secures €21.4 million - Seeking Alpha